Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2025-12-25 @ 12:24 PM
NCT ID:
NCT01569295
Group ID:
EG001
Title:
Placebo + Bendamustine + Rituximab
Description:
Placebo to match idelalisib administered orally twice daily + rituximab 375 mg/m\^2 on Day 1, then 500 mg/ m\^2 every 28 days administered intravenously for a total of 6 infusions + bendamustine 70 mg/m\^2/infusion on days 1 and 2 of each 28 day cycle administered intravenously for a total of 6 cycles (12 infusions).
Deaths Number Affected:
106
Deaths Number At Risk:
None
Serious Number Affected:
94
Serious Number At Risk:
209
Other Number Affected:
196
Other Number At Risk:
209
Study:
NCT01569295
Results Section:
NCT01569295
Adverse Events Module:
NCT01569295